Wednesday, 18 September 2019

New Zealand News

  • Real-Time Location Systems are a big hit in Asia

    New Zealand |  Analysis | By BioSpectrum Bureau  | 0 Comment | 01 Mar, 2013

    Singapore: Rising costs are compelling hospitals in South East Asia, Australia and New Zealand (ANZ) to streamline their operations, which, in turn, is opening up several opportunities for ...Read more

  • NZ firm to raise funds for Australia trial

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

    Singapore: Innate Immunotherapeutics, a New Zealand-based company, will raise further funds in the second half of 2012 to finance a multi-center phase IIB trial of MIS416 in patients with s...Read more

  • LanzaTech secures $15 mn debt financing from WTI

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

    Singapore: LanzaTech, a pioneer in waste-to-fuels and chemicals technology, closed $15 million in debt financing from Western Technology Investment (WTI), a private investment firm based i...Read more

  • Asia vaccine strategists call for collaboration

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2013

    Asia needs a solution, that goes beyond traditional structure, models and pathways, to meet the essential vaccine supply for public health, and stronger partnership between international pl...Read more

  • Clinical Network Services acquires Beltas' assets

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jan, 2013

    Singapore: Clinical Network Services (CNS), an Australia-based CRO offering integrated development services in the planning, implementation and delivery of phase I and II trials, has acquir...Read more

  • Clinical Network Services acquires BELTAS' business assets

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Australian CRO, Clinical Network Services (CNS), has acquired the business assets of its erstwhile New Zealand partner BELTAS, a CRO based in Auckland. Terms of the deal were not...Read more

  • LanzaTech wins TiE50 award

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 18 May, 2012

    Singapore: LanzaTech, a producer of low-carbon fuels and chemicals from waste gases, has for the second year in a row been named in the TiE50 as a leader in entrepreneurship, innovation, an...Read more

  • 5 major policy developments of 2012

    New Zealand |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 20 Dec, 2012

    The Year 2012 has seen crucial policy changes in the bioscience industry around the world. These changes that have taken place in 2012 hope to have an impact on the businesses of pharma, bi...Read more

  • What the future holds for the APAC CRO market?

    New Zealand |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Trial begins for vaccine that builds gluten tolerance

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

    Singapore: ImmusanT, an early-stage biotechnology company based in Cambridge, Massachusetts, has initiated clinical trials to evaluate Nexvax2, the first therapeutic vaccine for patients wi...Read more

  • New Zealand approves stem cell drug Prochymal

    New Zealand |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2012

    Singapore: Osiris Therapeutics has received consent from New Zealand to market its first-in-class stem cell therapy Prochymal (remestemcel-L) for the treatment of acute graft-vs-host diseas...Read more

  • IMCD acquires Aussie pharma distributor

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Global distribution firm IMCD Group has acquired Capitol Ingredients Australia, a Sydney headquartered speciality ingredients distributor focused on the nutraceuticals, personal ...Read more

  • NZ Smart device company receives $2.5m fund

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    ‎Singapore: Asia Pacific healthcare fund manager, BioScience Managers have plans to make investment of US$2.5 million (NZ$2 million) in innovative New Zealand asthma technology compan...Read more

  • NZ firm to shut bio-diesel unit due to lack of profit

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2012

    Singapore: New Zealand-based natural energy provider, Solid Energy (SE), is looking to shut down its biodiesel division. The state-owned business is considering the sale or closure of its s...Read more

  • INVISTA and LanzaTech sign biofuel deal

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 14 Aug, 2012

    Singapore: World-leading nylon producer, INVISTA, and biotechnology firm, LanzaTech signed a joint development agreement focused on bio-based butadiene. According to the agreement, INVISTA ...Read more

  • Genetic diagnostics companies speed ahead

    New Zealand |  Opinion | By Nandita Singh | 0 Comment | 28 Jun, 2013

    The playing field for research and development for genetic diagnostics has been leveled. The landmark decision by the US Supreme Court on June 13, 2013, stating that human genes cannot be p...Read more

  • Value Plastics expands with eyes on Asia Pacific

    New Zealand |  Influencers | By BioSpectrum Bureau  | 0 Comment | 28 May, 2012

    Colorado-based Value Plastics (VP) a Nordson company, designs, develops and manufactures a standard line of plastic tubing connectors. Due to its strong emphasis on cleanroom manufacturing ...Read more



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls